Cornea middle term preserving fluid

Original document(7 pages) Authorized document(7 pages) 中文版

Disclosed is a cornea middle term preserving fluid which comprises RPMI 1640 culture liquid, chondroitin sulfate, hyaluronic acid, HEPES cushioning liquid, dexamethasone, low-molecular-weight seaweed polysaccharides, Tobramycin or vancomycin, the preserving fluid has stabilized cell activity during storage period, and higher endothelial cell metabolizing function can be maintained than the US's Opthiol.

Application Number 申请号	200410091007	Application Date 申请日	2004.11.15
Title 名称	Cornea middle term preserving fluid
Publication Number 公开号	1631138	Publication Date 公开日	2005.06.29
Approval Pub. Date	2006.08.23	Granted Pub. Date	2006.08.23
International Classification 分类号	A01N1/02,A01P1/00
Applicant(s) Name 申请人	Shandong Eye Institute
Address 地址	266071
Inventor(s) Name 发明人	Dong Xiaoguang, Xie Lixin
Attorney & Agent 代理人	han zhendong

Long-acting tretnoin intraocular slow-releasing system
Health care desktop for reading and writing
Cornea activity preservative fluid
Slow-releasing medicine inplanted in eye and use thereof
Implantation slow release medicine in eyes
Aqua containing emodin with function of disinsection and sterilization
Method for protecting living body in radialization of UV-B using catechuic acid
Compound of six hydrogen-1,3,5-three(2-ethoxyl)sym-triazine and application thereof
Superior cornfield haulm herbicide
Superior paddy field haulm herbicide

Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.